Anethole trithione
 | |
 | |
| Clinical data | |
|---|---|
| ATC code | A16AX02 (WHO) |
| Identifiers | |
| |
| CAS Number |
532-11-6  |
| PubChem (CID) | 2194 |
| ChemSpider |
2109 |
| KEGG |
D01584 |
| ChEMBL |
CHEMBL178862 |
| Chemical and physical data | |
| Formula | C10H8OS3 |
| Molar mass | 240.365 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Anethole trithione, anetholtrithione, or anetholtrithion (JAN) is a drug used in the treatment of dry mouth. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer.[1]
Brand names
- Felviten
- Halpen
- Hepasulfol - Franco-Indian Pharmaceuticals
- Heporal
- Mucinol - Sanofi-Aventis
- Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma
- Sonicur - Solvay
- Sulfarlem - Solvay; Aguettant; Edward Keller; Sanofi-Aventis
- Sulfarlem S - EG Labo
- Tiopropen
- Tiotrifar
See also
References
- ↑ Anetholtrithione entry in the public domain NCI Dictionary of Cancer Terms. Retrieved September 13, 2008.
This article is issued from Wikipedia - version of the 6/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.